Emergo Therapeutics is a Durham, North Carolina-based pharmaceutical company dedicated to restoring immune balance. We’re bringing immune response back into balance, developing innovative treatments for a range of conditions, including long COVID and influenza-like illnesses.

Emergo’s approach centers on modulating the immune system without causing immunosuppression, addressing a critical need in the treatment of emerging pandemic viruses and other respiratory illnesses.

Founded in 2016, Emergo is led by a seasoned team of experts in research, clinical development, and regulatory affairs, with a strong commitment to revolutionizing patient outcomes. Our lead program, Norketotifen, is poised to address the significant unmet need for effective treatments for long COVID, a devastating illness affecting millions.

We are actively pursuing clinical trials and partnerships to accelerate the development and delivery of our groundbreaking therapies.

Emergo Therapeutics is committed to creating groundbreaking medications that restore equilibrium to your immune system.

Norketotifen | Emergo Therapeutics

Product description

Emergo Therapeutics Durham, United States (US)

Price: N/A

Emergo Therapeutics
Durham, United States (US)